Professor

Division of Pediatric Critical Care 

Dr. Michele Kong obtained her medical degree from the University of Calgary, Canada. She completed her pediatric critical care training at UAB. She is currently a translational physician scientist with a clinical practice in a tertiary 24-bed Pediatric Intensive Care Unit at Children's of Alabama. She is an NIH funded investigator, and leads several clinical trials, including her own R01 with a research portfolio focused on understanding the role of protease dysregulation in the pathogenesis of Respiratory Syncytial Virus (RSV) lung disease and acute lung injury in children. With the COVID-19 pandemic, her research work has extended to elucidating the epidemiology, pathophysiology and immune response to Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) in hospitalized children. In addition, Dr. Kong is the co-founder of KultureCity (www.kulturecity.org), an international non-profit that focuses on disability inclusion. She is also the founder and Medical Director of the Sensory Integration Program that centers on removing barriers to diagnosis and improving delivery of care, particularly for children with sensory, social and communication challenges at Children's of Alabama.